Greece vs Guinea: The number of people with susceptibility test result for rifampicin
Greece
45.08
in 2021
Guinea
44.93
in 2021
Greece rank
119th
Guinea rank
120th
The number of people with susceptibility test result for rifampicin over time
- Greece
- Guinea
How they compare
Greece currently reports 45.08 against 44.93 in Guinea, a difference of 0.15.
Across all 5 years both countries report, Greece has been ahead every year.
Greece ranks 119th and Guinea ranks 120th of 146 countries.
Greece has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Greece | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.64 | 17.48 | 38.16 | Greece |
| 2020s | 69.01 | 23.42 | 45.59 | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Greece or Guinea?
- Greece, at 45.08 against 44.93 in Guinea as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Greece and Guinea?
- 0.15, with Greece ahead.
- How many years of comparable data are there for Greece and Guinea?
- 5 years are reported by both, from 2017 to 2021.
- How do Greece and Guinea rank globally for the number of people with susceptibility test result for rifampicin?
- Greece ranks 119th and Guinea ranks 120th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.